Osteosarcoma in children;Ostéosarcomes de l'enfant

Oncologie

Volumn 8, Issue 6, 2006, Pages 546-550

  Marec Berard P ^a   Chotel, F ^b  

^a CENTRE LÉON BÉRARD   (France)

^b HÔPITAL DEBROUSSE   (France)

Author keywords

Children; Osteosarcoma; Therapeutics

Indexed keywords

ANTHRACYCLINE; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE;

ARTICLE; CANCER SURVIVAL; HISTOLOGY; HUMAN; IMAGING; OSTEOSARCOMA; POSTOPERATIVE PERIOD; PROGNOSIS;

EID: 33748415754     PISSN: 12923818     EISSN: 17652839     Source Type: Journal    
DOI: 10.1007/s10269-006-0453-8     Document Type: Article

References (33)

1. Arndt CA, Crist WM (1999) Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341: 342-52
2. Bacci G, Forni C, Ferrari S, et al. (2003) Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome. J Ped Hematol Oncol 25: 845-53
3. th protocol. Eur J Cancer 37: 2030-39
4. Bielack SS, Kempf-Bielack B, Delling G, et al. (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20: 776-90
5. Bloem JL, Bluemm RG, Taminiau AH, et al. (1987) Magnetic resonance imaging of primary malignant bone tumors. Radiographics 7(3): 425-45
6. Claude L, Rousmans S, Carrie C, et al. (2005) Standards and Options for the use of radiation therapy in the management of patients with osteosarcoma. Bull Cancer 92(10): 891-906
7. Cores EP, Holland JF, Wang JJ, et al. (1972) Doxorubicin in disseminated osteosarcoma. Jama 221: 1132-8
8. Dorfman HD, Czerniak B (1995) Bone cancers. Cancer 75: 203-10
9. Desandes E, Clavel J, Berger C, et al. (2004) Cancer incidence among children in France, 1990-1999. Pediatr Blood Cancer 43(7): 749-57
10. Eilber F, Giuliano A, Eckardt J, et al. (1987) Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 5(1): 21-6
11. Fuchs N, Bielack SS, Epler D, et al. (1998) Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 9: 893-9
12. Fuchs B, Pritchard DJ (2002) Etiology of osteosarcoma. Clin Orthop (397): 40-52
13. Gasparini M, Rouesse J, van Oosterom A, et al. (1985) Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Cancer Treat Rep 69: 211-3
14. Goorin AM, Schwartzentruber DJ, Devidas M, et al. (2003) Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: pediatric Oncology Group Study POG-8651. J Clin Oncol 21(8): 1574-80
15. Hillmann A, Ozaki T, et al. (2000) Familial occurrence of osteosarcoma: a case report and review of the litterature. J Cancer Clin Oncol 126: 497-502
16. Harris MB, Gieser P, Goorin AM, et al. (1998) Treatment of metastatic osteosarcoma at diagnosis: a pediatric Oncologgy Group Study. J Clin Onc 16: 3641-48
17. Huvos AG, Rosen G, Marcove RC, et al. (1977) Primary osteogenic sarcoma. Pathologic aspects in 20 patients after treatment with chemotherapy, in bloc resection and prosthetic bone replacement. Arch Pathol Lab Med 101: 14-18
18. Jaffe N, Paed D, Farber S, et al. (1973) Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy. Cancer 31: 1367-73
19. Link MP, Goorin AM, Miser AW, et al. (1986) The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314(25): 1600-6
20. Marina N, Gebhardt M, Teot L, Gorlick R (2004) Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9(4): 422-41
21. Marti C, Kroner T, Remagen W, et al. (1985) High-dose ifosfamide in advanced osteosarcoma. Cancer Treat Rep 69: 115-73
22. Meyers PA, Heller G, Healey J. et al. (1992) Chemotherapy for non metastatic osteogenic sarcoma % the Memorial Sloan-Kettering experience. J Clin Oncol 10: 5-15
23. Meyers PA, Schwartz CL, Krailo M, et al. (2005) Osteosarcoma: a randomized, prospective trial of the addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin and High-Dose Methotrexate. J Clin Oncol 23: 2004-11
24. Mialou V, Philip T, Kalifa C, et al. (2005) Metastatic osteosarcoma at diagnosis: prognostic: factors and long-term outcome: the French pediatric experience. Cancer 104: 1100-9
25. Nagarajan R, Clohisy DR, Neglia JP, et al. (2004) Function and quality-of-life of survivors of pelvic and lower extremity osteosarcoma and Ewing's sarcoma: the Childhood Cancer Survivor Study. Br J Cancer 91(11): 1858-65
26. Parkin DM, Stiller CA, Nectoux J (1993) International variations in the incidence of childhood bone tumours. Int J Cancer 53: 371-6
27. Provisor AJ, Ettinger LJ, Nachman JB, et al. (1997) Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 15: 76-84
28. Rosen G, et al. (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49: 1221-30
29. Saeter G (2003) European Society for Medical Oncology. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Ewing's sarcoma of bone. Ann Oncol 14(8): 1167-8
30. Osteogenic sarcoma (1995) Prognostic factors for long term survival. Cancer 75(5): 1084-93
31. Smeland S, Muller C, Alvegard TA, et al. (2003) Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 39: 488-94
32. Wang Lisa L (2005) Biology of Osteogenic Sarcoma. Cancer J 11: 294-305
33. Widhe B, Widhe T (2000) Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma, J. Bone Joint Surg 82A: 667-74